1. Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes.
   Sekeres MA, Maciejewski JP, Giagounidis AA, Wride K, Knight R, Raza A, List AF.
   J Clin Oncol. 2008 Nov 17. [Epub ahead of print]
   PMID: 19018091 [PubMed - as supplied by publisher]
   Related Articles
2. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
   Wang SA, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA.
   Haematologica. 2008 Nov 10. [Epub ahead of print]
   PMID: 19001281 [PubMed - as supplied by publisher]
   Related Articles
3. Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities.
   Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA.
   Cancer. 2008 Nov 5;113(12):3331-3340. [Epub ahead of print]
   PMID: 18988232 [PubMed - as supplied by publisher]
   Related Articles
4. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.
   Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP.
   Mod Pathol. 2008 Nov;21(11):1394-402. Epub 2008 Sep 12.
   PMID: 18839018 [PubMed - in process]
   Related Articles
5. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
   Raza A, Mehdi M, Mumtaz M, Ali F, Lascher S, Galili N.
   Cancer. 2008 Oct 1;113(7):1596-604.
   PMID: 18720364 [PubMed - indexed for MEDLINE]
   Related Articles
6. Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML).
   Galili N, Devemy E, Raza A.
   J Hematol Oncol. 2008 Jul 10;1:8.
   PMID: 18616802 [PubMed - in process]
   Related Articles - Free article in PMC
7. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia.
   Zota V, Miron PM, Woda BA, Raza A, Wang SA.
   J Clin Oncol. 2008 Apr 20;26(12):2040-1. No abstract available. Erratum in: J Clin Oncol. 2008 Jun;26(18):3110.
   PMID: 18421057 [PubMed - indexed for MEDLINE]
   Related Articles
8. An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome.
   Ebert BL, Galili N, Tamayo P, Bosco J, Mak R, Pretz J, Tanguturi S, Ladd-Acosta C, Stone R, Golub TR, Raza A.
   PLoS Med. 2008 Feb;5(2):e35.
   PMID: 18271621 [PubMed - indexed for MEDLINE]
   Related Articles - Free article in PMC
9. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.
   Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR.
   Nature. 2008 Jan 17;451(7176):335-9.
   PMID: 18202658 [PubMed - indexed for MEDLINE]
   Related Articles
10. Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
    Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF.
    Blood. 2008 Jan 1;111(1):86-93. Epub 2007 Sep 24.
    PMID: 17893227 [PubMed - indexed for MEDLINE]
    Related Articles
11. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.
    Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA.
    Leuk Res. 2008 Apr;32(4):553-8. Epub 2007 Sep 20.
    PMID: 17888511 [PubMed - indexed for MEDLINE]
    Related Articles
12. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.
    Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang SA.
13. Current treatment options: impact of cytogenetics on the course of myelodysplasia.
    Galili N, Cerny J, Raza A.
    Curr Treat Options Oncol. 2007 Apr;8(2):117-28. Review.
    PMID: 17634837 [PubMed - indexed for MEDLINE]
    Related Articles
14. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion.
    Wang SA, Yue G, Hutchinson L, Landry ML, Hasserjian RP, Hao S, Galili N, Raza A, Woda BA.
    Br J Haematol. 2007 Jul;138(2):271-5. Epub 2007 Jun 3. No abstract available.
    PMID: 17542981 [PubMed - indexed for MEDLINE]
    Related Articles
15. Clustering in the incidence of myelodysplastic syndromes.
    Ma X, Selvin S, Raza A, Foti K, Mayne ST.
    Leuk Res. 2007 Dec;31(12):1683-6. Epub 2007 May 15.
    PMID: 17507092 [PubMed - indexed for MEDLINE]
    Related Articles
16. Myelodysplastic syndromes: incidence and survival in the United States.
    Ma X, Does M, Raza A, Mayne ST.
    Cancer. 2007 Apr 15;109(8):1536-42.
    PMID: 17345612 [PubMed - indexed for MEDLINE]
    Related Articles
17. Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
    Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Le Beau MM, Rowley JD, Liu PP, Wolff L.
    Cancer Res. 2007 Feb 1;67(3):992-1000.
    PMID: 17283131 [PubMed - indexed for MEDLINE]
    Related Articles
18. A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.
    Fenaux P, Raza A, Mufti GJ, Aul C, Germing U, Kantarjian H, Cripe L, Kerstens R, De Porre P, Kurzrock R.
    Blood. 2007 May 15;109(10):4158-63. Epub 2007 Jan 30.
    PMID: 17264294 [PubMed - indexed for MEDLINE]
    Related Articles
19. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".
    Kay NE, Shanafelt TD, Strege AK, Lee YK, Bone ND, Raza A.
    Leuk Res. 2007 Jul;31(7):899-906. Epub 2007 Jan 22.
    PMID: 17241660 [PubMed - indexed for MEDLINE]
    Related Articles - Free article in PMC
20. Low-dose decitabine and high-risk MDS.
    Raza A, Raza FZ, Galili N.
    Blood. 2006 Dec 15;108(13):4291; author reply 4291-2. No abstract available.
    PMID: 17148594 [PubMed - indexed for MEDLINE]
    Related Articles